Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis

Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis

Abstract Introduction Patients with psoriasis report pruritus as their most bothersome symptom. Tapinarof cream 1% once daily demonstrated significant efficacy versus vehicle and was well tolerated in adults with mild to severe plaque psoriasis in two 12-week trials: PSOARING 1 (NCT03956355) and PSO...

Full description

Bibliographic Details
Main Authors: Leon Kircik, Matthew Zirwas, Shawn G. Kwatra, G. Michael Lewitt, Holly Glover, Tomas Chao, Philip M. Brown, David S. Rubenstein, Anna M. Tallman
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-12-01
Series:Dermatology and Therapy
Subjects:
Itch
Pruritus
Phase 3 PSOARING trials
Plaque psoriasis
Tapinarof cream 1% QD
Topical therapy
Online Access:https://doi.org/10.1007/s13555-023-01068-x

Internet

https://doi.org/10.1007/s13555-023-01068-x

Similar Items